Trials / Completed
CompletedNCT02600195
Reduction of Infection in Neonatal Intensive Care Units Using the Evidence-based Practice for Improving Quality
Reduction of Infection in Neonatal Intensive Care Units Using the Evidence-based Practice for Improving Quality: A Cluster Randomised Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15,600 (estimated)
- Sponsor
- Children's Hospital of Fudan University · Academic / Other
- Sex
- All
- Age
- 120 Days
- Healthy volunteers
- Not accepted
Summary
This 4-year cluster randomized controlled trial aims to determine whether implementation of Evidence-based Practice for Improving Quality (EPIQ) method can reduce hospital-acquired infection in Chinese Neonatal Intensive Care Units (NICUs).
Detailed description
Following randomization into two groups, the intervention NICUs (n = 12) will receive training in the EPIQ method and then develop, implement, and document evidence-based practice changes to reduce hospital-acquired infection. Compliance with practice changes and neonatal outcomes will be monitored. NICUs will receive quarterly feedback on their progress, as well as access to implementation support. Control NICUs (n = 12) will collect neonatal data and continue to provide standard care. Study subjects will be all preterm infants born at \<34 weeks' gestation and admitted to participating NICUs during the trial (estimated n = 5,200 per year). Data analysis will be conducted to compare neonatal outcomes and health-care resources used between the intervention and control groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Evidence-based Practice for Improving Quality (EPIQ) method | The intervention NICUs (n = 12) will receive training in the Evidence-based Practice for Improving Quality (EPIQ) method and then develop, implement, and document evidence-based practice changes to reduce hospital-acquired infection. Compliance with practice changes and neonatal outcomes will be monitored. NICUs will receive quarterly feedback on their progress, as well as access to implementation support. |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2018-04-01
- Completion
- 2018-04-30
- First posted
- 2015-11-09
- Last updated
- 2018-08-07
Locations
24 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02600195. Inclusion in this directory is not an endorsement.